Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorEryilmaz, Fahri
dc.contributor.authorFarooque, Umar
dc.date.accessioned2021-11-01T15:05:38Z
dc.date.available2021-11-01T15:05:38Z
dc.date.issued2021
dc.identifier.issn2168-8184
dc.identifier.urihttps://doi.org/10.7759/cureus.15139
dc.identifier.urihttps://hdl.handle.net/11491/7352
dc.description.abstractIntroduction This brief study shows the consumption of two medications that are related to those patients who have gone through the complicated procedure of craniotomy. The basic aim of these drugs is to subside the aftereffects of the procedure like postoperative nausea and vomiting in patients. Hereby, the study outlines the functional efficiency of dexamethasone along with the metoclopramide and dexamethasone alone. Materials and methods Randomly two groups were listed of 120 patients that have undergone elective craniotomy with ASA I-II. These groups were called out as group A and group B. Group A was under the medication of combination of dexamethasone and metoclopramide 8 mg and 10 mg, respectively, induced separately while group B was induced with 8 mg of dexamethasone along with 2 ml of normal saline. These drugs were induced right before anesthesia. The procedure from here on gets the same for both groups. After the surgical approach, a verbal evaluation was taken from the members of each group to collect specific data accordingly within the first 24 hours. As the method is double-blinded thus the patients were unaware of the ongoing research study. In any case of a mishap, rescue antiemetic drugs were also considered for the patients who would have experienced uncontrolled nausea and vomiting in the timeframe. Results The results show that only 16.7% of the patients from group A showed signs of nausea and only 5% showed vomiting while 31.7% of the patients from group B showed signs of nausea and 11.7% showed vomiting. It clearly showed that the patients tend to have either no sign of nausea and vomiting or showed little controllable nausea and vomiting when induced with dexamethasone and metoclopramide compared to those who were induced with the dexamethasone alone. Conclusions Postoperative nausea and vomiting are studied in terms of those who had undergone craniotomy. This study shows the prophylaxis of adverse effects of postoperative nausea and vomiting between the two groups under the influence of altered drugs. Thus, the results were noticeably in the favor of the combination treatment of dexamethasone and metoclopramide.en_US
dc.language.isoengen_US
dc.publisherCureus Incen_US
dc.relation.ispartofCureusen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectmetoclopramideen_US
dc.subjectdexamethasoneen_US
dc.subjectcranial surgeryen_US
dc.subjectnauseaen_US
dc.subjectneurosurgeryen_US
dc.subjectvomitingen_US
dc.titleA Clinical Research on the Impact of Dexamethasone Versus Dexamethasone-Metoclopramide Combination in Reducing Postoperative Vomiting and Nausea After Cranial Surgeryen_US
dc.typearticleen_US
dc.department[Belirlenecek]en_US
dc.identifier.volume13en_US
dc.identifier.issue5en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Eryilmaz, Fahri] Hittite Univ, Neurol Surg, Corum Erol Olcok Training & Res Hosp, Corum, Turkey; [Farooque, Umar] Dow Univ Hlth Sci, Neurol, Karachi, Pakistanen_US
dc.contributor.institutionauthor[Belirlenecek]
dc.identifier.doi10.7759/cureus.15139
dc.description.wospublicationidWOS:000653502100009en_US
dc.description.pubmedpublicationidPubMed: 34159037en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster